The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost Utility Analysis of Second Line Hormonal Therapy in Advanced Breast Cancer: A Comparison of Two Aromatase Inhibitors to Megestrol Acetate (Megace).
 
Leah L. Zullig
No Relationships to Disclose
 
Valerie Smith
No Relationships to Disclose
 
Jennifer Lindquist
No Relationships to Disclose
 
Christina D. Williams
No Relationships to Disclose
 
Morris Weinberger
No Relationships to Disclose
 
Dawn Provenzale
No Relationships to Disclose
 
George L. Jackson
No Relationships to Disclose
 
Michael J. Kelley
Research Funding - Bavarian Nordic; Bristol-Myers Squibb; FibroGen; Threshold Pharmaceuticals
 
Susanne Danus
No Relationships to Disclose
 
Hayden B Bosworth
No Relationships to Disclose